Oral Anxiolytic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Oral Anxiolytic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 4

NCT06874452

An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surger…

Phacoemulsification is one of the most used surgical methods for cataract surgery today, and the surgeries are under the anesthetic and sedative to make it comf…

Taiwan250 participantsStarted 2025-03-25

Treatment: Alprazolam (Xanax), Placebo Tablets

RecruitingNot Applicable

NCT06826417

Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety

This study aims to explore the effects of anxiety traits on pain, anxiety, and anesthesia satisfaction in patients undergoing cataract surgery under topical ane…

Taiwan400 participantsStarted 2024-01-02

Treatment: Xanax, placebo tablets

All recent trials (3 shown)

TerminatedPhase 2

NCT00322803

ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One…

This study is designed to investigate if 600 mg ELB139 given orally t.i.d. to patients suffering from panic disorder is effective in reducing anxiety evoked by…

Germany, Netherlands24 participantsStarted 2006-05

Treatment: ELB139